Larvol Delta - atai-Life-Sciences-Announces-Completion-of-Enrollment-in-Phase-2b-Clinical-Trial-Evaluating-BPL003-for-TreatmentResistant-Depression

5-methoxy-dimethyltryptamine dry-powder intranasal (BPL-003) - Beckley Psytech

https://www.globenewswire.com/news-release/2025/03/05/3037279/0/en/atai-Life-Sciences-Announces-Completion-of-Enrollment-in-Phase-2b-Clinical-Trial-Evaluating-BPL-003-for-Treatment-Resistant-Depression.html

Mar 5, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next